Category: CBSA News

Presenting Companies Represent Transformative Technologies from the Rocky Mountain West DENVER, July 31, 2024 – Colorado BioScience Association (CBSA) highlights the momentum and opportunities in Colo...

Fitzsimons Innovation Community and so many more call this thriving community home. By: Fitzsimons Innovation Community If you ask the Economic Development team for Adams County Government what drives...

Patients say Upper Payment Limits (UPLs) won’t make their medicines more affordable. Colorado’s Prescription Drug Affordability Board (PDAB) hasn’t listened.   Colorado’s PDAB was created to...

Public and Private Investments and Federal Grants Contribute to Total Colorado’s life sciences community raised $1.2 billion in the first two quarters of 2024. Public and private capital, as well as f...

7/16/24  CBSA has consistently advocated for PBM reform at the state and federal level. Following the release of an interim report from the Federal Trade Commission (FTC) blasting the business pr...

On July 3, the Colorado Prescription Drug Affordability Board (PDAB or Board) voted to initiate the upper payment limit (UPL) rulemaking process for two more drugs, Stelara and Cosentyx, after deeming...

A conversation with Fitzsimons Innovation Community partner and Master Plan creator, Tryba Architects. By: Fitzsimons Innovation Community In creating the plan for a 184-acre innovation campus, Fitzsi...

CBSA and BIO urge you to reach out to Senator Hickenlooper to encourage his support of S.4583, a bill that would reauthorize the rare pediatric disease priority review voucher (PPRV) program before it...

This past week, the CBSA team represented our community and shared our expertise on prescription drug affordability at the BIO International Convention and through a series of virtual events:  El...

CBSA and our partners at Biotechnology Innovation Organization (BIO) welcome the joint plan that the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), and the U....